EVA MARÍA
CIRUELOS GIL
Profesora asociada de Ciencias de la Salud
Christie Hospital NHS Foundation Trust
Mánchester, Reino UnidoPublicaciones en colaboración con investigadores/as de Christie Hospital NHS Foundation Trust (4)
2022
-
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
Annals of Oncology, Vol. 33, Núm. 12, pp. 1250-1268
2019
-
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)
Annals of Oncology, Vol. 30, Núm. 5, pp. 766-773
2013
-
Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer
Journal of Clinical Oncology, Vol. 31, Núm. 20, pp. 2586-2592
2009
-
Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer
Clinical Cancer Research, Vol. 15, Núm. 4, pp. 1452-1459